IMCR
NASDAQStockImmunocore Holdings plc
$31.22-1.30 (-4.00%)
52-Week Range
$24.53
$40.22
Key Stats
Market Cap
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.82
Volume
156.5K
Avg Volume
397.6K
Performance
1M
-5.42%
3M
-15.65%
6M
-9.82%
YTD
-8.11%
1Y
+6.85%
3Y
-40.67%
5Y
-15.97%
Price Chart
ETF Exposure
IMCR is held by 15 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| GERM | ETFMG Treatments, Testing and Advancements ETF | 3.67% |
| BBP | Virtus Biotech ETF | 1.38% |
| SBIO | ALPS Medical Breakthroughs ETF | 1.08% |
| CANC | Tema Oncology ETF | 0.59% |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 0.20% |
| GWX | State Street SPDR S&P International Small Cap ETF | 0.13% |
| IBB | iShares Biotechnology ETF | 0.11% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.11% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.09% |
| ISCF | iShares International Small-Cap Equity Factor ETF | 0.09% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.07% |
| VALT | ETFMG Sit Ultra Short ETF | 0.02% |
| SILX | ETFMG Prime 2x Daily Junior Silver Miners ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| SPDW | State Street SPDR Portfolio Developed World ex-US ETF | 0.01% |
About IMCR ETF Exposure
Immunocore Holdings plc (IMCR) is held by 15 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $31.22. Investors can gain exposure to IMCR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IMCR, sorted by portfolio weight.